FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2022223746> ?p ?o ?g. }

• W2022223746 endingPage "2795" @default.
• W2022223746 startingPage "2788" @default.
• W2022223746 abstract "To characterize the expression pattern and role of galectin 3 and galectin 3 binding protein (G3BP) in rheumatoid arthritis (RA), in comparison with galectin 1, and to explore whether soluble galectin 3 and G3BP, investigated in serum, synovial fluid, or cell culture supernatant, are associated with disease.Synovial tissues from patients with RA or osteoarthritis (OA), as well as from healthy controls, were analyzed for galectins 1 and 3 and G3BP by in situ hybridization and immunohistochemistry. Levels of galectin 3 and G3BP in serum and synovial fluid from patients with RA and OA and controls, as well as in cell culture supernatants, were determined by enzyme-linked immunosorbent assay (ELISA). In vitro, the intracellular expression of galectin 3 in RA and OA synovial fibroblasts after modulation with tumor necrosis factor alpha (TNFalpha), interleukin-1beta (IL-1beta), and anti-CD40 monoclonal antibodies was measured by flow cytometry.In RA, galectin 3 messenger RNA and protein stained throughout the synovial membrane, whereas G3BP was particularly expressed at sites of bone destruction. In contrast, the expression of galectin 1 was not uniform in different RA specimens, and was never found at sites of invasion. In OA and normal synovial tissues, only a small number of cells were positive for galectins and/or G3BP. Galectin 3 was elevated in RA sera and synovial fluids, whereas G3BP was increased in RA synovial fluids only. In RA, serum galectin 3 correlated with C-reactive protein levels, whereas G3BP was associated with joint destruction and/or synovial cell activation as measured by the levels of cartilage oligomeric matrix protein. In vitro, RA synovial fibroblasts showed an increased release of galectin 3 into culture medium, as measured by ELISA, but decreased secretion of G3BP. In RA synovial fibroblasts with low basal expression of galectin 3, TNFalpha increased its intracellular level in a dose-dependent manner. In contrast, IL-1beta or anti-CD40 monoclonal antibodies showed no effect.Our data indicate that galectin 3 and G3BP are not only involved in inflammation, but also contribute to the activation of synovial fibroblasts. The intracellular accumulation of galectin 3 can be enhanced by TNFalpha. Thus, galectin 3 and G3BP represent novel markers of disease activity in RA." @default.
• W2022223746 created "2016-06-24" @default.
• W2022223746 creator A5002731323 @default.
• W2022223746 creator A5014051857 @default.
• W2022223746 creator A5027428785 @default.
• W2022223746 creator A5029785146 @default.
• W2022223746 creator A5040209339 @default.
• W2022223746 creator A5066831904 @default.
• W2022223746 creator A5073770232 @default.
• W2022223746 creator A5073899811 @default.
• W2022223746 creator A5086602394 @default.
• W2022223746 date "2003-10-01" @default.
• W2022223746 modified "2023-10-16" @default.
• W2022223746 title "Galectin 3 and its binding protein in rheumatoid arthritis" @default.
• W2022223746 cites W117529435 @default.
• W2022223746 cites W135884805 @default.
• W2022223746 cites W1496787899 @default.
• W2022223746 cites W1565381857 @default.
• W2022223746 cites W1967797132 @default.
• W2022223746 cites W1975476505 @default.
• W2022223746 cites W1977005214 @default.
• W2022223746 cites W1989815841 @default.
• W2022223746 cites W1996657758 @default.
• W2022223746 cites W1999067404 @default.
• W2022223746 cites W2004508492 @default.
• W2022223746 cites W2012855718 @default.
• W2022223746 cites W2033201741 @default.
• W2022223746 cites W2041856244 @default.
• W2022223746 cites W2046229657 @default.
• W2022223746 cites W2047892119 @default.
• W2022223746 cites W2048827022 @default.
• W2022223746 cites W2051036708 @default.
• W2022223746 cites W2052315444 @default.
• W2022223746 cites W2054022111 @default.
• W2022223746 cites W2060490044 @default.
• W2022223746 cites W2061460842 @default.
• W2022223746 cites W2072177473 @default.
• W2022223746 cites W2076428688 @default.
• W2022223746 cites W2082421146 @default.
• W2022223746 cites W2085534168 @default.
• W2022223746 cites W2091885982 @default.
• W2022223746 cites W2105367923 @default.
• W2022223746 cites W2105759494 @default.
• W2022223746 cites W2106004289 @default.
• W2022223746 cites W2137617448 @default.
• W2022223746 cites W2138162673 @default.
• W2022223746 cites W2141309671 @default.
• W2022223746 cites W2144426613 @default.
• W2022223746 cites W2146421447 @default.
• W2022223746 cites W2152348310 @default.
• W2022223746 cites W2155323332 @default.
• W2022223746 cites W2170555397 @default.
• W2022223746 cites W2312410155 @default.
• W2022223746 doi "https://doi.org/10.1002/art.11287" @default.
• W2022223746 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/14558084" @default.
• W2022223746 hasPublicationYear "2003" @default.
• W2022223746 type Work @default.
• W2022223746 sameAs 2022223746 @default.
• W2022223746 citedByCount "167" @default.
• W2022223746 countsByYear W20222237462012 @default.
• W2022223746 countsByYear W20222237462013 @default.
• W2022223746 countsByYear W20222237462014 @default.
• W2022223746 countsByYear W20222237462015 @default.
• W2022223746 countsByYear W20222237462016 @default.
• W2022223746 countsByYear W20222237462017 @default.
• W2022223746 countsByYear W20222237462018 @default.
• W2022223746 countsByYear W20222237462019 @default.
• W2022223746 countsByYear W20222237462020 @default.
• W2022223746 countsByYear W20222237462021 @default.
• W2022223746 countsByYear W20222237462022 @default.
• W2022223746 countsByYear W20222237462023 @default.
• W2022223746 crossrefType "journal-article" @default.
• W2022223746 hasAuthorship W2022223746A5002731323 @default.
• W2022223746 hasAuthorship W2022223746A5014051857 @default.
• W2022223746 hasAuthorship W2022223746A5027428785 @default.
• W2022223746 hasAuthorship W2022223746A5029785146 @default.
• W2022223746 hasAuthorship W2022223746A5040209339 @default.
• W2022223746 hasAuthorship W2022223746A5066831904 @default.
• W2022223746 hasAuthorship W2022223746A5073770232 @default.
• W2022223746 hasAuthorship W2022223746A5073899811 @default.
• W2022223746 hasAuthorship W2022223746A5086602394 @default.
• W2022223746 hasConcept C142724271 @default.
• W2022223746 hasConcept C153911025 @default.
• W2022223746 hasConcept C156293190 @default.
• W2022223746 hasConcept C159654299 @default.
• W2022223746 hasConcept C17991360 @default.
• W2022223746 hasConcept C203014093 @default.
• W2022223746 hasConcept C204232928 @default.
• W2022223746 hasConcept C204787440 @default.
• W2022223746 hasConcept C2776164576 @default.
• W2022223746 hasConcept C2776268809 @default.
• W2022223746 hasConcept C2777077863 @default.
• W2022223746 hasConcept C2777575956 @default.
• W2022223746 hasConcept C2777652487 @default.
• W2022223746 hasConcept C2778735756 @default.
• W2022223746 hasConcept C542903549 @default.
• W2022223746 hasConcept C553184892 @default.
• W2022223746 hasConcept C71924100 @default.

• next